ArticleCancer causes & control : CCC2026
Age-specific disparities in rural and urban survival among patients with IDH-wildtype glioblastoma: a population-based study.
Article in Cancer causes & control : CCC, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAccess to subspecialty neuro-oncologic care is uneven across the United States. Whether rural residence is linked to age-specific survival differences in IDH-wildtype glioblastoma (GBM) is unclear.
methodsWe used the Surveillance, Epidemiology, and End Results (SEER) 17 database to identify adults (≥ 18 years) with histologically confirmed IDH-wildtype GBM (diagnoses 2018-2022). Rural-urban residence followed 2013 USDA Rural-Urban Continuum Codes (1-3 urban; 4-9 rural). Overall survival (OS) was the primary endpoint. After confirming violation of proportional hazards, we fit multivariable accelerated failure time (AFT) models and report time ratios (TRs) adjusted for area of residence, age group (18-64 vs ≥ 65 years), sex, race, surgery, radiotherapy, and chemotherapy; age-specific effects were assessed by stratification.
resultsAmong 10,632 patients, 1,193 (11.2%) resided in rural and 9,439 (88.8%) in urban counties. Rural patients were slightly older and were less likely to receive radiotherapy (71.8 vs 76.7%) or chemotherapy (69.2 vs 73.4%); resection rates were similar (84.4 vs 83.8%). One- and two-year OS was 37 and 14% in rural areas versus 45% and 19% in urban areas. In adjusted AFT models, rural residence was associated with shorter survival (TR 0.89 95% CI 0.84-0.95). The association was more evident in adults aged 18-64 years (TR 0.86, 95% CI 0.79-0.94), whereas the estimate in those aged ≥ 65 years was smaller and not statistically significant (TR 0.95, 95% CI 0.87-1.03). Not receiving surgery (TR 0.59), radiotherapy (TR 0.51), or chemotherapy (TR 0.42) was strongly associated with shorter survival.
conclusionsRural residence was associated with shorter OS in IDH-wildtype GBM. The association was more evident in adults aged 18-64 years.
Indexed as
Identifiers
42348019What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.